High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis

Cancer

Volumn 74, Issue 12, 1994, Pages 3089-3096

  Wang, Dong‐Yu ^b   Xiang, Yun‐Yan ^a   Tanaka, Masamitsu ^a   Li, Xin‐Rong ^b   Li, Ji‐Lin ^c   Shen, Qiong ^b   Sugimura, Haruhiko ^a   Kino, Isamu ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ZHENGZHOU UNIVERSITY   (China)

^c Linxian Esophageal Tumor Hospital ^*  (China)

Author keywords

esophageal squamous cell carcinoma; high incidence area; immunohistochemistry; invasion; metastasis; p53 protein; pathology; prognosis

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CHINA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; GENE EXPRESSION; GENE MUTATION; GEOGRAPHIC PATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; CARCINOMA, SQUAMOUS CELL; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENES, P53; HUMAN; IMMUNOHISTOCHEMISTRY; LIFE TABLES; MALE; MIDDLE AGE; MUTATION; NEOPLASM INVASIVENESS; PROGNOSIS; PROTEIN P53; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE;

EID: 0028061941     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19941215)74:12<3089::AID-CNCR2820741205>3.0.CO;2-N     Document Type: Article

References (36)

1. Etiologic and epidemiologx factors of carcinoma of the esophagus
2. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis
3. Cytologic screening for esophageal cancer: results from 12,877 subjects from a high‐risk population in China
4. TP53 gene mutation profile in esophageal squamous cell carcinomas
5. p53 gene mutations in Barrett's epithelium and esophageal cancer
6. Overex pression of p53 protein in Barrett's syndrome with malignant transformation
7. p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow‐up study
8. Infectious agents in the etiology of esophageal cancer
9. New directions in molecular medicine
10. p53 mutations in human cancers
11. Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer
12. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas
13. In situ hybridization and immunohistochemistry of p53 tumor suppressor gene in human esophageal carcinoma
14. Enhancement of immunoreactivity among lymphoid malignant neoplasms in paraffin‐embedded tissues by refixation in zinc sulfate‐formalin
15. Antigen retrieval in formalin‐fixed, paraffin‐embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
16. Frequent mutation of the p53 gene in human esophageal cancer
17. Oncogenes and onco‐suppressor gene in adenocarcinoma of the oesophagus
18. Evaluation of p53 protein expression in Barrett's esophagus by two‐parameter flow cytometry
19. Intestinal differentiation and p53 gene alterations in Barrett's esophagus and esophageal adenocarcinoma
20. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations
21. p53 gene mutations in gastric and esophageal cancers
22. Sensitive detection of p53 gene mutations in esophageal endoscopic biopsy specimens by cell sorting combined with polymerase chain reaction single‐strand conformation polymorphism analysis
23. p53 gene mutations in esophageal cancer detected by polymerase chain reaction single‐strand conformation polymorphism analysis
24. Prognostic significance of human papillomavirus genomes (type‐16,‐18) and aberrant expression of p53 protein in human esophageal cancer
25. Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma
26. Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction
27. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas
28. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis
29. Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinugenesis
30. Widespread p53 overexpression in human malignant tumors
31. Immunohis‐tochemical evidence of p53 overexpression in gastric epithelial dysplasia
32. Nuclear DNA content, proliferating‐cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions
33. Overexpression of p53 is a late event in the development of malignant melanoma
34. Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation
35. p53 protein expression in breast cancer as related to histopathological characteristics and prognosis